fincash logo SOLUTIONS

Fincash » Search » Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd

Updated on July 14, 2019

Stock/Share Code - DRREDDY

Dr. Reddys Laboratories is a leading India-based pharmaceutical company. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and New Chemical Entities (NCEs).

Below is the details of DRREDDY Dr Reddys Laboratories Ltd

Market Cap₹44,478 Cr.
Current Price ₹2,613.15 as on 19 Jul 19
52 Week High / Low Price₹2,965.2 / ₹1,872.95
Face Value₹5
Stock P/E34.82
Book Value₹763.8
Dividend Yield0.75 %
ROCE5.09 %
ROE4.58 %
Sales Growth (3yrs)-2.22 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has been maintaining a healthy dividend payout of 35.78%
Cons: Stock is trading at 3.51 times its book value The company has delivered a poor growth of 2.26% over past five years. Promoter holding is low: 26.77% Company has a low return on equity of 9.35% for last 3 years.

Dr Reddys Laboratories Ltd Price Chart

Dr Reddys Laboratories Ltd Price Chart

Dr Reddys Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹151.2 26.06 ₹98,336.74 Cr. 0.49 ₹635.88 Cr. -52.63 2.68 7163.92 10.41
2. Cipla ₹536.7 29.66 ₹45,028.9 Cr. 0.54 ₹357.68 Cr. 57.90 19.09 4403.98 9.64
3. Dr Reddy's Labs 34.82 ₹44,478.27 Cr. 0.75 ₹202.8 Cr. 14.77 6.13 2645.20 5.09
4. Dr Reddy's Labs 22.81 ₹44,478.27 Cr. 0.75 ₹455.4 Cr. 67.36 13.39 4029.60 7.75
5. Piramal Enterp. ₹1,903.95 25.32 ₹44,159.07 Cr. 1.02 ₹456.86 Cr. -88.42 23.02 3679.67 8.85
6. Aurobindo Pharma ₹552.4 16.21 ₹39,396.97 Cr. 0.37 ₹585.38 Cr. 15.67 30.70 5292.20 22.85
7. Biocon ₹240.3 43.80 ₹32,514 Cr. 0.18 ₹213.7 Cr. 63.88 30.72 1528.80 8.41
8. Torrent Pharma. ₹17.25 36.27 ₹26,480.39 Cr. 0.89 -₹152 Cr. -37.72 8.67 1856.00 13.23

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Dr Reddys Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
YOY Sales Growth %-14.34%-9.93%4.85%-0.77%-3.42%-14.2%-1.77%5.6%25.26%16.71%8.27%6.13%
Material Cost %24.4%25.26%22.53%30.54%27.41%29.35%25.64%30.08%26.25%26.84%28.5%32.74%
Employee Cost %21.65%18.28%18.78%15.77%21.56%20.07%18.89%18.59%17.84%19.12%17.27%18.52%
Operating Profit236547641309148314536326575565687437
OPM %11%21%25%13%7%14%21%13%22%21%25%17%
Other Income3926489604940487335759373
Profit before tax442409529163-10140372196401433570296
Tax %8%23%17%-36%28%28%20%10%18%20%30%32%
Net Profit409313439223-7101297177329346399203

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales Growth %97.21%-14.93%23.59%8.5%16.19%28.55%24.2%16.22%2.91%2.81%-5.56%-3.71%%
Material Cost %25.71%31.27%26.77%27.23%30.27%28.81%30.7%25.6%28.17%25.79%26.52%28.11%%
Manufacturing Cost %8.97%13.48%14.41%12.75%7.93%7.97%6.95%10.98%11.44%11.97%13.23%14.47%%
Employee Cost %6.61%10.34%9.46%10.87%13.36%12.85%13.6%14.6%14.89%16.45%18.55%19.69%%
Other Cost %22.44%27.98%28.93%24.51%25.73%27.41%25.03%20.44%21.62%25.72%23.48%23.52%%
Operating Profit1,4345708501,1111,1901,5481,9862,7622,3912,0651,7711,3302,263
OPM %36%17%20%25%23%23%24%28%24%20%18%14%21%
Other Income11719110121211982142152223325566204275
Profit before tax1,3665847301,0851,0521,2591,7532,4542,0601,6771,5446971,701
Tax %14%19%23%22%15%28%28%21%18%18%10%19%
Net Profit1,1774755618468939121,2661,9331,6791,3741,3845671,277
EPS in Rs69.4527.6232.2548.2550.9851.5771.98113.5694.4880.5683.4834.15
Dividend Payout %5%13%19%22%21%26%20%16%20%25%24%59%

Compounded Sales Growth

  • 10 Years:: 10.77%
  • 5 Years:: 2.26%
  • 3 Years:: -2.22%
  • TTM:: 13.53%

Compounded Profit Growth

  • 10 Years:: 1.21%
  • 5 Years:: -15.59%
  • 3 Years:: -31.03%
  • TTM:: 125.27%

Return on Equity

  • 10 Years:: 13.47%
  • 5 Years:: 12.77%
  • 3 Years:: 9.35%
  • Last Year:: 4.58%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital84848484858585858585838383
Equity Capital83.9684.184.284.484.684.884.985.185.285.382.98383
Other Liabilities1,0948771,2971,7861,7312,1702,1382,5362,7322,6642,7922,9572,672
Trade Payables598.49613.37801194.3604.3847.3890.91013.7920.8971.81031.71287.61031.6
Total Liabilities5,7986,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35416,248
Fixed Assets6829871,2111,3161,6911,8972,3872,7483,2494,4384,8424,7174,683
Gross Block1291.191750.22157.32425.730253507.84208.74899.75815.675808675.49223.6
Accumulated Depreciation609.15762.8946.51110.1133416111821.72151.42566.23141.93833.34506.3
Other Assets4,0052,9863,8703,6474,5885,4316,8328,4008,8927,6978,2648,3257,231
Trade receivables1055.7897.71419.71060.51770.51943.52963.94561.54711.73889.54405.44203.83717.7
Cash Equivalents1456.71536.7384.436866.2849919.1665.1901.4202.166.8120.7113.2
Loans n Advances1004.82911.11331.21321.4776.5679.61026.61045.81000.41427.91395.61520.977.9
Total Assets5,7986,1517,1968,2639,28710,42312,02214,53116,49217,82816,74817,35416,248

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity8865544861,2532461,4032899061,7862,7471,0161,539
Profit from operations1547.31744.5992.11440.61328.52140.42438.43472.62655.92765.12192.81661.3
Working Capital Changes-535.36-115.1-334.932.8-871-343.6-1773.8-2024.1-390.6379-854.151.3
Taxes paid-118.15-75.2-175.9-220.2-211.2-393.8-375.8-543-479.2-397.2-322.8-174
Cash from Investing Activity-397-1,520-744-1,117-609-425-524-874-2,031-1,9191,430-1,180
Fixed Assets Purchased-388.43-455.5-545.1-383-696.4-601.2-580.2-871.8-962.5-1083.7-985.1-768.9
Fixed Assets Sold82.82.918.72.90227.
Investments purchased-74.6-2348.9-1373.3-2695.8-1162.4-1370.4-1186.5-3581-3594.6-6532.5-4850.2-6062
Investments sold33.191235.11634.92110.21260.211781262.63106.92609.66420.46952.75627.8
Cash from Financing Activity31746106-15261-19515228189-693-2,582-304
Proceeds from Shares1002.961.
Proceeds from Borrowings114.75324.2636.6730.52103.32205.53026.54439.527372576.20165.4
Repayment of Borrowings-708.01-196-439.7-749.1-1221.8-2116.4-2516.5-3523-2122-2786.9-613.6-0.1
Interest Paid-49.36-9.8-18-12.1-4.2-62.9-87.5-82.8-68.7-75.1-63.6-70.6
Dividends Paid-43.75-73.7-73.8-123.2-814.1-221.6-270.8-297.9-357.4-407.3-335.3-399.2
Net Cash Flow806-920-152-16-302783-8460-56135-13554

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %36%12%13%18%15%17%20%23%16%12%11%5%
Debtor Days979712586123105129171172138165164
Inventory Turnover8.505.966.045.535.355.645.876.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Dr Reddys Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.